This model is consistent with the previous reports of a dose-dependent weakening of cell junctions induced by ectopic expression of Podocalyxin and the tight correlation between Podocalyxin overexpression and breast cancer metastatic index [8], [11]. Here, PODXL is linked to breast cancer.